Product Information

LAMOTRIGINE ODT 100 MG TABLET is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $1.6250 per EA under NDC 00115994101. Its NADAC has been published 78 times since Apr 9, 2025.

FDA first approved this application on Jul 15, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the LAMOTRIGINE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

LAMOTRIGINE ODT 100 MG TABLET

LAMOTRIGINE
$1.6250per EA
High Outlier

Strength

100 mg/1

NDC

00115994101

Classification

Generic

Dosage Form

TABLET, ORALLY DISINTEGRATING

Route

ORAL

Effective Date

9/23/2026

Active Ingredients

LAMOTRIGINE

Approval Type

Generic (ANDA)

FDA Application

ANDA200828

FDA Approved

7/15/2013

TE Code

AB

On Market Since

12/27/2018

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity
Dihydrofolate Reductase Inhibitors
Mood Stabilizer
Organic Cation Transporter 2 Inhibitors

Price Statistics

The NADAC for LAMOTRIGINE ODT 100 MG TABLET has been published 78 times since Apr 9, 2025, and over the history we have for it it has declined 21.5%. The table below summarizes its recorded NADAC range and movement.

Current price$1.6250 per EA
All-time high$2.4577 (Sep 10, 2025)
All-time low$1.6250 (Sep 23, 2026)
52-week high$2.4101
52-week low$1.6250
Median price$2.0086
Average price$2.0524
Largest weekly change-9.7% (Sep 23, 2026)
Weeks tracked78
Tracking sinceApr 9, 2025

Price History

1W

0.0%

1M

-9.7%

3M

-18.5%

6M

-13.0%

1Y

-32.6%

3Y

N/A

5Y

N/A

All

-21.5%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 97% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LAMOTRIGINE ODT 100 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LAMOTRIGINE ODT 100 MG TABLET, manufactured by Amneal Pharmaceuticals of New York LLC, is $1.6250 per EA (NDC 00115994101), effective Sep 30, 2026.

How has the price of LAMOTRIGINE ODT 100 MG TABLET changed over time?

Over the history we have for it, the NADAC for LAMOTRIGINE ODT 100 MG TABLET has declined 21.5%. It has been tracked across 78 weekly CMS publications since Apr 9, 2025.

What are the highest and lowest recorded NADAC prices for LAMOTRIGINE ODT 100 MG TABLET?

Since Apr 9, 2025, the NADAC for LAMOTRIGINE ODT 100 MG TABLET has ranged from a low of $1.6250 (Sep 23, 2026) to a high of $2.4577 (Sep 10, 2025), with a median of $2.0086 per EA.

Are there cheaper alternatives to LAMOTRIGINE ODT 100 MG TABLET?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SUBVENITE 100 MG TABLET, is $0.0487 per EA — about 97% below LAMOTRIGINE ODT 100 MG TABLET.

Who manufactures LAMOTRIGINE ODT 100 MG TABLET?

LAMOTRIGINE ODT 100 MG TABLET (NDC 00115994101) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.